Amanda Guitián Caamaño

Dr Amanda Guitián Caamaño is a postdoctoral researcher in the Freeman's Lab at University College Dublin (UCD). She obtained her biology degree from the University of A Coruña (Spain) in 2017, and her PhD cum laude from the same institution in 2024. Her Ph.D. research, conducted at the Biomedical Research Institute of A Coruña (INIBIC), focused on metastatic melanoma and the development of novel therapies to combat treatment resistance. She was awarded a prestigious PFIS grant from the Instituto de Salud Carlos III (ISCIII) to support her work. During her PhD, she completed a pre-doctoral stay at the MRC Laboratory of Molecular Biology (LMB) in Cambridge (UK), funded by the EMBO Short-Term Fellowship. She has also completed research stays at the CIB-Margarita Salas in Madrid and the Centro Singular de Investigación en Medicina Molecular y Enfermedades Crónicas (CiMUS) in Santiago de Compostela, both in Spain.

Currently, in collaboration with Hooke Bio, Dr Guitián Caamaño's research focuses on evaluating the efficacy of the Mera platform compared to existing 3D culture systems to optimise T-cell therapies. Her work focuses on liver cancer (HEPG2) and osteosarcoma (SaOS2), with the aim of demonstrating real-time cellular interactions and therapeutic effects of T-cell treatments.